Fund Holdings — DIADEMA PARTNERS LP

Total Portfolio Value
$143.56M
Total Bought
$74.51M
Total Sold
$93.38M
Net Transaction
-$18.87M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
REGENERON PHARMACEUTICALS(REGN)5,60730,160+24,5532,94416,95811.81%+14,014
INDIVIOR PLC0254,252+254,25206,1304.27%+6,130
BRISTOL-MYERS SQUIBB CO(BMY)0130,000+130,00005,8634.08%+5,863
ASCENDIS PHARMA A/S(ASND)027,572+27,57205,4823.82%+5,482
ALNYLAM PHARMACEUTICALS INC(ALNY)010,000+10,00004,5603.18%+4,560
NEKTAR THERAPEUTICS(NKTR)075,000+75,00004,2682.97%+4,268
ABIVAX SA(ABVX)041,620+41,62003,5132.45%+3,513
ANI PHARMACEUTICALS INC(ANIP)031,400+31,40002,8762.00%+2,876
ARDELYX INC0400,000+400,00002,2041.54%+2,204
ALKERMES PLC(ALKS)072,079+72,07902,1621.51%+2,162
APOGEE THERAPEUTICS INC(APGE)10,57264,250+53,6784592,5531.78%+2,094
ROIVANT SCIENCES LTD(ROIV)0120,000+120,00001,8161.26%+1,816
TERNS PHARMACEUTICALS INC259,852323,159+63,3079692,4271.69%+1,458
VAXCYTE INC(PCVX)198,285218,285+20,0006,4467,8635.48%+1,416
NOVO-NORDISK A S(NVO)025,000+25,00001,3870.97%+1,387
HARMONY BIOSCIENCES HLDGS IN(HRMY)050,000+50,00001,3780.96%+1,378
AMYLYX PHARMACEUTICALS INC(AMLX)0100,000+100,00001,3590.95%+1,359
AVIDITY BIOSCIENCES INC030,000+30,00001,3070.91%+1,307
IMMUNOCORE HLDGS PLC(IMCR)104,384124,384+20,0003,2764,5193.15%+1,243
MANNKIND CORP(MNKD)0212,475+212,47501,1410.79%+1,141
SUPERNUS PHARMACEUTICALS INC(SUPN)022,348+22,34801,0680.74%+1,068
CATALYST PHARMACEUTICALS INC050,000+50,00009850.69%+985
BIOMARIN PHARMACEUTICAL INC(BMRN)192,877212,877+20,00010,60211,5298.03%+927
ARCTURUS THERAPEUTICS HLDGS(ARCT)048,811+48,81109000.63%+900
XERIS BIOPHARMA HOLDINGS INC074,753+74,75306080.42%+608
CYTOMX THERAPEUTICS INC(CTMX)0185,286+185,28605910.41%+591
MODERNA INC(MRNA)020,000+20,00005170.36%+517
AYTU BIOPHARMA INC0272,670+272,67005130.36%+513
TENAYA THERAPEUTICS INC(TNYA)0315,519+315,51905110.36%+511
VISTAGEN THERAPEUTICS INC(VTGN)403,922349,789-54,1338081,2420.86%+434
EQUILLIUM INC(EQ)0300,000+300,00004290.30%+429
PYXIS ONCOLOGY INC(PYXS)0150,000+150,00003330.23%+333
PELTHOS THERAPEUTICS INC(PTHS)010,498+10,49802940.20%+294
NEUPHORIA THERAPEUTICS INC021,452+21,45202530.18%+253
FOGHORN THERAPEUTICS INC(FHTX)050,000+50,00002450.17%+245
OVID THERAPEUTICS INC(OVID)0187,739+187,73902440.17%+244
VENTYX BIOSCIENCES INC071,204+71,20402210.15%+221
MIND MEDICINE MINDMED INC158,536105,891-52,6451,0291,2480.87%+220
PACIRA BIOSCIENCES INC(PCRX)58,92658,92601,4081,5191.06%+110
ANAPTYSBIO INC03,295+3,29501010.07%+101
TVARDI THERAPEUTICS INC(TVRD)02,185+2,1850850.06%+85
RELAY THERAPEUTICS INC(RLAY)43,61643,61601512280.16%+77
ALECTOR INC266,023136,023-130,0003724030.28%+30
PMV PHARMACEUTICALS INC(PMVP)011,300+11,3000160.01%+16
PROQR THRAPEUTICS N V
SHS EURO
157,694157,69403223360.23%+14
PURETECH HEALTH PLC(PRTCY)7,3247,32401261350.09%+9
ZAI LAB LTD(ZLAB)3,7850-3,785130—-13
SUMMIT THERAPEUTICS INC(SMMT)9320-932200—-20
REVIVA PHARMACEUTCLS HLDGS I2,735,4572,506,921-228,5361,0429240.64%-118
ELEVATION ONCOLOGY INC362,9350-362,9351330—-133
VIKING THERAPEUTICS INC(VKTX)197,468193,689-3,7795,2335,0903.55%-143
REVOLUTION MEDICINES INC(RVMD)79,07959,079-20,0002,9092,7591.92%-150
ELEDON PHARMACEUTICALS INC(ELDN)64,6130-64,6131750—-175
TREVI THERAPEUTICS INC(TRVI)185,83085,830-100,0001,0167850.55%-231
UROGEN PHARMA LTD(URGN)150,00090,000-60,0002,0551,7961.25%-259
REPLIMUNE GROUP INC(REPL)32,4830-32,4833020—-302
NUVALENT INC5,0000-5,0003820—-381
PHATHOM PHARMACEUTICALS INC(PHAT)40,2940-40,2943860—-386
CLIMB BIO INC(CLYM)702,135136,488-565,6478712740.19%-596
ARVINAS INC(ARVN)96,4550-96,4557100—-710
PROTAGONIST THERAPEUTICS INC76,18551,185-25,0004,2113,4002.37%-811
SCPHARMACEUTICALS INC217,6230-217,6238290—-829
89BIO INC98,3820-98,3829660—-966
OLEMA PHARMACEUTICALS INC(OLMA)253,6570-253,6571,0810—-1,081
COGENT BIOSCIENCES INC(COGT)392,21397,813-294,4002,8161,4050.98%-1,411
MERCK & CO INC(MRK)20,0000-20,0001,5830—-1,583
ULTRAGENYX PHARMACEUTICAL IN(RARE)53,9859,189-44,7961,9632760.19%-1,686
VIRIDIAN THERAPEUTICS INC(VRDN)122,0610-122,0611,7060—-1,706
ITEOS THERAPEUTICS INC206,2000-206,2002,0560—-2,056
SCHOLAR ROCK HLDG CORP(SRRK)62,9260-62,9262,2290—-2,229
ARGENX SE(ARGX)5,9740-5,9743,2930—-3,293
GILEAD SCIENCES INC(GILD)30,0000-30,0003,3260—-3,326
VERTEX PHARMACEUTICALS INC(VRTX)10,0000-10,0004,4520—-4,452
NEUROCRINE BIOSCIENCES INC(NBIX)94,04237,754-56,28811,8205,3003.69%-6,520
JAZZ PHARMACEUTICALS PLC(JAZZ)104,47323,140-81,33311,0873,0502.12%-8,037
TG THERAPEUTICS INC(TGTX)371,44860,748-310,70013,3682,1951.53%-11,174
ELI LILLY & CO(LLY)14,8160-14,81611,5500—-11,550
SOLENO THERAPEUTICS INC284,152177,330-106,82223,80611,9888.35%-11,819
AMGEN INC(AMGN)52,1000-52,10014,5470—-14,547
Page 1 of 1
DIADEMA PARTNERS LP — 13F Holdings — Q3 2025 | TickerTrail